A Phase 1 study of PET imaging for predicting immunotherapy efficacy in DLBCL
Recruiting NCT06755775
Study Description
Using PET Imaging to Predict the Effectiveness of Immunotherapy in Diffuse Large B-cell Lymphoma
Study Details
- Registry ID:
- NCT06755775
- Conditions:
- Diffuse Large B-Cell Lymphoma
- Phase:
- Target Enrollment:
- 150 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School
Shanghai, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.